Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin

Cancer Science

Volumn 101, Issue 9, 2010, Pages 2011-2018

  Yoshioka, Toshiaki ^a,d   Nishikawa, Yuji ^a,d   Ito, Reiko ^a   Kawamata, Makiko ^a   Doi, Yuko ^a   Yamamoto, Yohei ^a   Yoshida, Masayuki ^a   Omori, Yasufumi ^a   Kotanagi, Hitoshi ^b   Masuko, Takashi ^c   Enomoto, Katsuhiko ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA RED CROSS HOSPITAL   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; COLONIC NEOPLASMS; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA5BETA1; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEUREGULIN-1; PHOSPHORYLATION; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77955954607     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01640.x     Document Type: Article

References (34)

1. Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 1993, 204:171-80.
2. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-8.
3. Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol 2005, 92:347-59.
4. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997, 71:612-9.
5. Bresalier RS, Byrd JC, Brodt P, Ogata S, Itzkowitz SH, Yunker CK. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer 1998, 76:556-62.
6. Kitakata H, Nemoto-Sasaki Y, Takahashi Y, Kondo T, Mai M, Mukaida N. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 2002, 62:6682-7.
7. Matsushita Y, Kitajima S, Goto M. Selectins induced by interleukin-1beta on the human liver endothelial cells act as ligands for sialyl Lewis X-expressing human colon cancer cell metastasis. Cancer Lett 1998, 133:151-60.
8. Sturm JW, Magdeburg R, Berger K. Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 2003, 107:11-21.
9. Enns A, Gassmann P, Schluter K. Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 2004, 8:1049-59. discussion 60
10. Martinez-Hernandez A, Amenta PS. The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch 1993, 423:1-11.
11. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ. Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 1991, 88:9402-6.
12. Otter M, Kuiper J, Rijken D, van Zonneveld AJ. Hepatocellular localisation of biosynthesis of vitronectin. Characterisation of the primary structure of rat vitronectin. Biochem Mol Biol Int 1995, 37:563-72.
13. Klemke RL, Yebra M, Bayna EM, Cheresh DA. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin. J Cell Biol 1994, 127:859-66.
14. Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA, Cheresh DA. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest 1997, 99:1390-8.
15. Enns A, Korb T, Schluter K. Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer 2005, 41:1065-72.
16. Yoshioka T, Masuko T, Kotanagi H. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res 1998, 89:177-85.
17. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001, 2:127-37.
18. Zvibel I, Brill S, Papa M, Halpern Z. Hepatocyte-derived soluble factors regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capability. Tumour Biol 2000, 21:187-96.
19. Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J, Kumar R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J Biol Chem 1998, 273:28238-46.
20. Vijapurkar U, Kim MS, Koland JG. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling. Exp Cell Res 2003, 284:291-302.
21. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003, 20:203-13.
22. Schluter K, Gassmann P, Enns A. Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 2006, 169:1064-73.
23. Long L, Nip J, Brodt P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res 1994, 54:3732-7.
24. Kawamoto K, Onodera H, Kan S, Kondo S, Imamura M. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer 1999, 85:18-25.
25. Miyamoto S, Nakamura M, Shitara K. Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers. Clin Cancer Res 2005, 11:3494-502.
26. Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Cancer Gene Ther 2004, 11:419-30.
27. Ishida H, Sadahiro S, Suzuki T, Ishikawa K, Tajima T, Makuuchi H. c-erbB-2 protein expression and clinicopathologic features in colorectal cancer. Oncol Rep 2000, 7:1229-33.
28. Gambaletta D, Marchetti A, Benedetti L, Mercurio AM, Sacchi A, Falcioni R. Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 2000, 275:10604-10.
29. Guo W, Pylayeva Y, Pepe A. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006, 126:489-502.
30. Bublil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 2007, 19:124-34.
31. Sliwkowski MX, Schaefer G, Akita RW. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 1994, 269:14661-5.
32. Xue C, Liang F, Mahmood R. ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 2006, 66:1418-26.
33. Ueno Y, Sakurai H, Tsunoda S. Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells. Int J Cancer 2008, 123:340-7.
34. Maurer CA, Friess H, Kretschmann B. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998, 29:771-7.